Overview
Frank Zenke practices in Darmstadt, Germany. Mr. Zenke is rated as an Elite expert by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Ataxia-Telangiectasia, Telangiectasia, Drug Induced Dyskinesia, and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Ataxia-Telangiectasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Ataxia-TelangiectasiaMr. Zenke isElite. Learn about Ataxia-Telangiectasia.
- Distinguished
- TelangiectasiaMr. Zenke isDistinguished. Learn about Telangiectasia.
- Experienced
- Drug Induced DyskinesiaMr. Zenke isExperienced. Learn about Drug Induced Dyskinesia.
- Lung CancerMr. Zenke isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Zenke isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Ovarian CancerMr. Zenke isExperienced. Learn about Ovarian Cancer.
- Renal Cell Carcinoma (RCC)Mr. Zenke isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Small Cell Lung Cancer (SCLC)Mr. Zenke isExperienced. Learn about Small Cell Lung Cancer (SCLC).